HDL Cholesterol: Metabolic Pathways and Drug Developments.  4th International Conference, March 2-4, 2003, Cambridge, MA, USA.
Scriabine
Alexander
A
Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000378:metabolism; D008076:Cholesterol, HDL / Q000378:metabolism*; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism
D000924:Anticholesteremic Agents; D000975:Antioxidants; D008076:Cholesterol, HDL; D008074:Lipoproteins